- 现金
- 62111 元
- 精华
- 26
- 帖子
- 30437
- 注册时间
- 2009-10-5
- 最后登录
- 2022-12-28
|
Bull Cancer. 2018 Mar 19. pii: S0007-4551(18)30076-6. doi: 10.1016/j.bulcan.2018.02.003. [Epub ahead of print]
[Hepatocellular carcinoma: Increase in incidence or future plague?] [Article in French]
Raoul JL1, Raimbourg J2, Hiret S2, Adhoute X3, Senellart H2.
Author information
1Institut de cancérologie de l'Ouest, département d'oncologie médicale, site de Nantes, boulevard J.-Monod, 44805 Saint-Herblain cedex, France. Electronic address: [email protected].2Institut de cancérologie de l'Ouest, département d'oncologie médicale, site de Nantes, boulevard J.-Monod, 44805 Saint-Herblain cedex, France.3Hôpital Saint-Joseph, département d'hépato-gastroentérologie, 26, boulevard de Louvain, 13008 Marseille, France.
AbstractHepatocellular carcinoma is the third most frequent cause of cancer death worldwide, particularly in Asia and Africa. Most cases complicate an underlying liver cirrhosis due to hepatitis B or C chronic virus infection or alcoholic abuse. But, following the current epidemics of obesity and type 2 diabetes, it appears that these diseases, associated in metabolic syndrome, are responsible for non alcoholic fatty liver disease at risk of HCC frequently before the stage of cirrhosis. Recent hypotheses consider that in the near future, cancer deaths due to HCC will overpass in USA those due to breast or colorectal cancers. Governments should develop policies to prevent obesity, type 2 diabetes and the metabolic syndrome as well as fight against alcoholism and hepatitis B and C virus infections.
KEYWORDS: Carcinome hépatocellulaire; Cirrhose; Cirrhosis; Diabetes; Diabète; Epidemiology; Hepatocellular carcinoma; Obesity; Obésité; Épidémiologie
PMID:29567280DOI:10.1016/j.bulcan.2018.02.003
|
|